Fig. 1From: Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profilingHeatmap illustrating selected clinicopathologic features of the patients included in this study according to the PTEN status. Each column represents a patient, each row a parameter, color-coded according to the legend below. PTEN-L, PTEN low (i.e. decreased expression); PTEN-WT, PTEN wild-type (i.e. retained expression) HR, hormone receptorsBack to article page